Description
This peptide is a CD8+ T cell epitope of HIV-1 reverse transcriptase (RT) subtype A2.1. This peptide may be used in the design of HIV vaccines, as it includes a target sequence that is recognizable by cytotoxic lymphocytes.
This peptide is a CD8+ T cell epitope of HIV-1 reverse transcriptase (RT) subtype A2.1. This peptide may be used in the design of HIV vaccines, as it includes a target sequence that is recognizable by cytotoxic lymphocytes.
Purity | ≥95% |
---|---|
Formula | C46H78N12O12 |
Formula Wt. | 991.21 |
Synonym | HIV-1 RT Epitope; IV9 (476-484) |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet | H3278 Info Sheet PDF |
---|
Peter K, Men Y, Pantaleo G, et al. Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants. Vaccine. 2001 Jul 20;19(30):4121-9. PMID: 11457536.
Shankar P, Sprang H, Lieberman J. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):111-20. PMID: 9768618.